MassDevice.com +7 | The top 7 med-tech stories for the week of February 6, 2012.
February 11, 2012 by MassDevice staff
Stryker suddenly loses its CEO, Boston Scientific plans acquisitions, CMS releases TAVI guidelines, AdvaMed reframes its med-tech tax repeal efforts, Smith & Nephew pays $22 million to settle a bribery beef, Soteira CEO Larry Jasinski details the company's troubles with the FDA and patient advocates Consumer Union demand more oversight from MDUFMA III.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.
7. Consumer group demands more med-tech oversight from MDUFMA III
Consumer Union demanded that a new user fee deal the medical device industry brokered with the FDA include more stringent oversight of med-tech makers. "We shouldn't be used as guinea pigs when it comes to something as serious as a medical implant," according to the organization's website. "Medical devices should not be ticking time bombs!"
6. MassDevice Podcast: Soteira CEO Larry Jasinski
Soteira CEO Larry Jasinski is no stranger to adversity. In the last 5 years the spinal fusion device maker has overcome criticism from the research community and mid-application surprises from the FDA, but its newest 510(k) win is a testament to its persistence.
Legal News, News Well, Plus 7, MDUFMA, Medical Device Tax, Mergers & Acquisitions, Personnel, Replacement Heart Valves
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Mobilizing on the back end of a disaster
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
Navigation
NEWS
Medical device tax: Consultant calls offshoring concerns 'horse hockey'
Concerns that the medical device tax will push companies to lay off workers and move operations...
FDA clears OrthoSensor's Verasense knee replacement device
The FDA clears OrthoSensor's Verasense device, designed to help surgeons fit knee replacement...
ArtVentive Medical wins CE Mark for peripheral catheter
ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular...
Recalls: FDA makes Endologix catheter introducer recall Class I
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
pSivida gains big on buyout rumor
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...
